Clinical Trials in Edmonds, United States
Locations / Edmonds, United States
Delta Trials lists 81 clinical trials conducted in Edmonds, United States, making it a notable site of clinical research activity. These trials addressing 497 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Edmonds research landscape.
81
Total Trials
497
Conditions
1
Terminated since 2020
Browse by condition (497 total)
- Stage iiib lung cancer ajcc v8 6 trialsAll Stage iiib lung cancer ajcc v8 trials
- Recurrent ovarian carcinoma 5 trialsAll Recurrent ovarian carcinoma trials
- Acute myeloid leukemia 5 trialsAll Acute myeloid leukemia trials
- Metastatic malignant solid neoplasm 5 trialsAll Metastatic malignant solid neoplasm trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Stage iiia lung cancer ajcc v8 4 trialsAll Stage iiia lung cancer ajcc v8 trials
- Malignant solid neoplasm 4 trialsAll Malignant solid neoplasm trials
- Recurrent endometrial carcinoma 4 trialsAll Recurrent endometrial carcinoma trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Small lymphocytic lymphoma 3 trialsAll Small lymphocytic lymphoma trials
- All Recurrent ovarian clear cell adenocarcinoma trials
- All Recurrent primary peritoneal carcinoma trials
- All Endometrial mixed cell adenocarcinoma trials
- Myelodysplastic syndrome 3 trialsAll Myelodysplastic syndrome trials
- Stage iv lung cancer ajcc v8 3 trialsAll Stage iv lung cancer ajcc v8 trials
- Endometrioid adenocarcinoma 3 trialsAll Endometrioid adenocarcinoma trials
- Recurrent fallopian tube carcinoma 3 trialsAll Recurrent fallopian tube carcinoma trials
- Multiple myeloma 3 trialsAll Multiple myeloma trials
- Recurrent malignant solid neoplasm 3 trialsAll Recurrent malignant solid neoplasm trials